Equasens

Equasens FCF Margin

The Free Cash Flow Margin of Equasens (EQS.PA) as of Oct 17, 2026 is 19.91 %. In the previous year, Free Cash Flow Margin was 16.57 % — a change of 20.20% (higher).

FCF Margin

19.91 %

YoY

20.20%

Last updated:

Free Cash Flow Margin of Equasens is 2025 19.91 % . Free Cash Flow Margin of Equasens was 2024 16.57 % . It decreases by 20.20% higher compared to the previous year.

The Equasens FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
11.90 EUR
Jan 1, 2019
14.92 EUR
Jan 1, 2020
16.03 EUR
Jan 1, 2021
19.21 EUR
Jan 1, 2022
21.84 EUR
Jan 1, 2023
19.64 EUR
Jan 1, 2024
16.57 EUR
Jan 1, 2025
19.91 EUR
The Equasens FCF Margin history
YEARFCF MarginYoY
19.91 %+20.20%
16.57 %-15.66%
19.64 %-10.05%
21.84 %+13.67%
19.21 %+19.85%
16.03 %+7.45%
14.92 %+25.37%
11.90 %-20.80%
15.02 %+16.31%
12.92 %-20.61%
16.27 %+17.19%
13.88 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Equasens Stock analysis

What does Equasens do? Pharmagest Interactive SA is a leading provider of digital solutions for pharmacies and healthcare providers. The company was founded in France in 1986 and is headquartered in Villers-lès-Nancy. The company offers a wide range of software solutions for healthcare providers and pharmacies. Its main business areas include pharmacy management systems, healthcare management solutions, and telemedicine solutions. Pharmagest Interactive SA's pharmacy management systems include software solutions for inventory management, prescription management, and billing. The company also provides e-learning courses and training for pharmacies. Its healthcare management solutions focus on patient data management, with features such as patient records, appointment scheduling, and prescription management. These solutions are used by healthcare providers to optimize patient data management and improve patient care. Pharmagest Interactive SA also offers telemedicine solutions, including remote visit applications, online consultations, and teleconsultations. These solutions are particularly useful for patients in rural areas or with limited mobility. The company's products and services include Crossway, a pharmacy management software; LGPI, a patient management software for hospitals and healthcare providers; Noviatek, a digital prescription management system; and Monolog, a cloud-based platform for telemedicine services. In summary, Pharmagest Interactive SA provides a variety of digital solutions for pharmacies and healthcare providers, focusing on optimizing patient data management, inventory management, and billing. The company is also a pioneer in telemedicine solutions. Equasens is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Equasens stock

Free Cash Flow Margin of Equasens is 19.91 % in 2025.

Free Cash Flow Margin of Equasens changed from 16.57 % to 19.91 %, representing a 20.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Equasens since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Equasens with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Equasens

All Key Metrics — Equasens